gavin
Topics Engaged In
-
- Topic
- Voices
- Posts
- Last Post
-
-
The landscape of predictive biomarkers for ATR inhibition in Chinese solid-tumor
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
Pan-cancer analysis of FGFR1-3 genomic alterations to reveal a complex molecular
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
Employing RNA sequencing to enhance treatment options for cancer patients.
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
IDH1 mutation detection in plasma circulating tumor DNA (ctDNA) and association
Started by:
in: Clinical Trials
- 1
- 1
- 4 years, 3 months ago
-
Phase II study of pembrolizumab plus olaparib in the treatment of patients with
Started by:
in: Chemotherapy & More
- 1
- 1
- 4 years, 3 months ago
-
The prevalence of KRASG12C mutations utilizing circulating tumor DNA (ctDNA) in
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
Combination immunotherapy with ipilimumab and nivolumab in patients with advance
Started by:
in: Chemotherapy & More
- 1
- 1
- 4 years, 3 months ago
-
Correlation of pathogenic POLE mutations with clinical benefit to immune checkpo
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
Phase II basket trial of olaparib and durvalumab in patients (pts) with isocitra
Started by:
in: Clinical Trials
- 1
- 1
- 4 years, 3 months ago
-
Efficacy of telotristat ethyl: A peripheral tryptophan hydroxylase inhibitor tha
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
The natural history of fibroblast growth factor receptor (FGFR)-altered cholangi
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
Perioperative MVT-5873, a fully human monoclonal antibody against a CA 19-9 epit
Started by:
in: Surgery, Resection & Transplant Treatment Options
- 1
- 1
- 4 years, 3 months ago
-
Final results from the phase I study expansion cohort of the selective FGFR inhi
Started by:
in: Clinical Trials
- 1
- 1
- 4 years, 3 months ago
-
The landscape of predictive biomarkers for ATR inhibition in Chinese solid-tumor